In this first-ever proof-of-concept study for the therapeutic potential of human iPSC-derived cells in a pulmonary disease,  Christine Happle and colleagues use Chipcytometry to analyse the successful transplantation of these cells in a humanized mouse model of hereditary pulmonary alveolar proteinosis (herPAP).

Contact Us

Please tell us how we can help you.

Not readable? Change text. captcha txt

Start typing and press Enter to search